SCHEMBL1477561

SCHEMBL1477561

O=[N+]([O-])c1ccccc1CCS(=O)(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
TSHR P16473 1/20 0.55
HPGD P15428 1/20 0.50
CA12 O43570 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
F2 P00734 1/20 0.45
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45
PRSS3 P35030 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
MMP13 P45452 1/20 0.45
CTSD P07339 1/20 0.45
NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3840820 0.85 TDP1 (0.53) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL64725 0.84 ALDH1A1 (0.56) ALDH1A1TSHRHPGDCA12MEN1
Hydrochloric Acid SCHEMBL27512791 0.82 ALDH1A1 (0.55) ALDH1A1TSHRHPGDCA12MEN1
SCHEMBL10628482 0.82 ALDH1A1 (0.55) ALDH1A1TSHRHPGDCA12MEN1
SCHEMBL7783353 0.82 ALDH1A1 (0.59) ALDH1A1TSHRHPGDCA12MEN1
SCHEMBL7783117 0.82 GPR35 (0.47) ALDH1A1TSHRMEN1KMT2AF2
SCHEMBL3202573 0.80 ALDH1A1 (0.72) ALDH1A1TSHRHPGDMEN1KMT2A
SCHEMBL9479744 0.80 BACE1 (0.43) ALDH1A1TSHRHPGDCA12KMT2A
SCHEMBL7784570 0.78 CYP1A2 (0.58) ALDH1A1TSHRHPGDMEN1KMT2A
SCHEMBL7784575 0.78 CYP1A2 (0.58) ALDH1A1TSHRHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915467-B2 layer contains a cyclic olefin resin having an epoxy group and a photoacid generator; low stress properties and adhesion; prevent breakage of the semiconductor wafer in a process for grinding the backside to make them thinner SUMITOMO BAKELITE COMPANY, LTD. (JP) 2011-03-29 US disclosed
US-20100193122-A1 PROCESS FOR MANUFACTURING ELECTRONIC DEVICE SUMITOMO BAKELITE CO., LTD. (JP) 2010-08-05 US disclosed
US-7768089-B2 Semiconductor device SUMITOMO BAKELITE COMPANY, LTD. (JP) 2010-08-03 US disclosed
EP-2161744-A1 ELECTRONIC DEVICE MANUFACTURING METHOD Sumitomo Bakelite Co., Ltd. (JP) 2010-03-10 EP disclosed
US-20100016285-A1 HETEROCYCLIDENE-N-(ARYL) ACETAMIDE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2010-01-21 US disclosed
US-20090294887-A1 Semiconductor device SUMITOMO BAKELITE COMPANY LIMITED (JP) 2009-12-03 US disclosed
US-20080090176-A1 Semiconductor Wafer And Semiconductor Device SUMITOMO BAKELITE CO., LTD. (JP) 2008-04-17 US disclosed
EP-1804291-A1 SEMICONDUCTOR WAFER AND SEMICONDUCTOR DEVICE Sumitomo Bakelite Company, Limited (JP) 2007-07-04 EP disclosed
US-20060228562-A1 Semiconductor device, resin composition for buffer coating, resin composition for die bonding, and resin composition for encapsulating SUMITOMO BAKELITE COMPANY LIMITED (JP) 2006-10-12 US disclosed
CN-1462298-A Radiation-sensitive composition changing in refractive index and utilization thereof JSR CORP (JP) 2003-12-17 CN disclosed
EP-0880075-B1 Radiation sensitive resin composition JSR CORP (JP) 2001-10-17 EP disclosed
US-5958648-A Radiation sensitive resin composition JSR CORPORATION (JP) 1999-09-28 US disclosed
EP-0880075-A1 Radiation sensitive resin composition JSR Corporation (JP) 1998-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016285-A1 HETEROCYCLIDENE-N-(ARYL) ACETAMIDE DERIVATIVE CCNY, CCND3, NSD3 ALDH1A1 1904/4885TSHR 1731/4885HPGD 2117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.